{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:48:22Z","timestamp":1788781702879,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T00:00:00Z","timestamp":1311033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11064-011-0548-5","type":"journal-article","created":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T20:43:30Z","timestamp":1311021810000},"page":"2244-2249","source":"Crossref","is-referenced-by-count":48,"title":["Effects of Zingerone [4-(4-Hydroxy-3-Methoxyphenyl)-2-Butanone] and Eugenol [2-Methoxy-4-(2-Propenyl)Phenol] on the Pathological Progress in the 6-Hydroxydopamine-Induced Parkinson\u2019s Disease Mouse Model"],"prefix":"10.1007","volume":"36","author":[{"given":"Hideaki","family":"Kabuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko T.","family":"Yamanushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,19]]},"reference":[{"key":"548_CR1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1749-6632.1996.tb39063.x","volume":"786","author":"T Kondo","year":"1996","unstructured":"Kondo T (1996) Parkinson\u2019s disease and free radicals. Mechanism of neurodegeneration and neuroprotection. Ann NY Acad Sci 786:206\u2013216","journal-title":"Ann NY Acad Sci"},{"key":"548_CR2","first-page":"363","volume":"49","author":"RJ Tolwani","year":"1999","unstructured":"Tolwani RJ, Jakowec MW, Petzinger GM et al (1999) Experimental models of Parkinson\u2019s disease: insights from many models. Lab Anim Sci 49:363\u2013371","journal-title":"Lab Anim Sci"},{"key":"548_CR3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/BF00978370","volume":"18","author":"R Andrew","year":"1993","unstructured":"Andrew R, Watson DG, Best SA et al (1993) The determination of hydroxydopaminea and other trace animals in the urine of Parkinsonian patients and normal controls. Neurochem Res 18:1175\u20131177","journal-title":"Neurochem Res"},{"key":"548_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","volume":"50","author":"Y Glinka","year":"1997","unstructured":"Glinka Y, Gassen M, Youdim MBH (1997) Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl 50:55\u201366","journal-title":"J Neural Transm Suppl"},{"key":"548_CR5","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1046\/j.1471-4159.1995.64041703.x","volume":"64","author":"R Kumar","year":"1995","unstructured":"Kumar R, Agarwal AK, Seth PK (1995) Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 64:1703\u20131707","journal-title":"J Neurochem"},{"key":"548_CR6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1023\/A:1021152115752","volume":"24","author":"H Kabuto","year":"1999","unstructured":"Kabuto H, Yokoi I, Iwata IE et al (1999) EPC-K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depression in the mouse striatum by up-regulation of catalase activity. Neurochem Res 24:1543\u20131548","journal-title":"Neurochem Res"},{"key":"548_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11064-005-2606-3","volume":"30","author":"H Kabuto","year":"2005","unstructured":"Kabuto H, Nishizawa M, Tada M et al (2005) Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. Neurochem Res 30:325\u2013332","journal-title":"Neurochem Res"},{"key":"548_CR8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1248\/bpb.30.423","volume":"30","author":"H Kabuto","year":"2007","unstructured":"Kabuto H, Tada M, Kohno M (2007) Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum. Biol Pharm Bull 30:423\u2013427","journal-title":"Biol Pharm Bull"},{"key":"548_CR9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.fct.2004.11.019","volume":"43","author":"M Ito","year":"2005","unstructured":"Ito M, Murakami K, Yoshino M (2005) Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation. Food Chem Toxicol 43:461\u2013466","journal-title":"Food Chem Toxicol"},{"key":"548_CR10","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/0006-2952(92)90318-D","volume":"43","author":"E Nagababu","year":"1992","unstructured":"Nagababu E, Lakshmaiah N (1992) Inhibitory effect of eugenol on non-enzymatic lipid peroxidation in rat river mitochondria. Biochem Pharmacol 43:2393\u20132400","journal-title":"Biochem Pharmacol"},{"key":"548_CR11","first-page":"117","volume":"111","author":"AC Reddy","year":"1992","unstructured":"Reddy AC, Lokesh BR (1992) Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem 111:117\u2013124","journal-title":"Mol Cell Biochem"},{"key":"548_CR12","first-page":"133","volume":"30","author":"TP Krishnakantha","year":"1993","unstructured":"Krishnakantha TP, Lokesh BR (1993) Scavenging of superoxide anions by spice principles. Indian J Biochem Biophys 30:133\u2013134","journal-title":"Indian J Biochem Biophys"},{"key":"548_CR13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000117070","volume":"34","author":"N Ogawa","year":"1994","unstructured":"Ogawa N (1994) Levodopa and dopamine agonists in the treatment of Parkinson\u2019s diseases: advantages and disadvantages. Eur Neurol Suppl 34:320\u2013328","journal-title":"Eur Neurol Suppl"},{"key":"548_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0076-6879(84)05064-3","volume":"105","author":"LW Oberley","year":"1984","unstructured":"Oberley LW, Spitz DR (1984) Assays of superoxide dismutase activity in tumor tissue. Method Enzymol 105:457\u2013464","journal-title":"Method Enzymol"},{"key":"548_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Method Enzymol 105:121\u2013126","journal-title":"Method Enzymol"},{"key":"548_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OJ Lowry","year":"1951","unstructured":"Lowry OJ, Rosebrough NJ, Farr AL et al (1951) Protein measurement with folin-phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"548_CR17","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ et al (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem 52:1830\u20131836","journal-title":"J Neurochem"},{"key":"548_CR18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","volume":"32","author":"LM Ambani","year":"1975","unstructured":"Ambani LM, Van Woert MH, Murphy S (1975) Brain peroxidase and catalase in Parkinson disease. Arch Neurol 32:114\u2013118","journal-title":"Arch Neurol"},{"key":"548_CR19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0304-3940(85)90078-3","volume":"58","author":"SJ Kish","year":"1985","unstructured":"Kish SJ, Morito C, Hornykiewicz O (1985) Glutathion peroxidase activity in Parkinson\u2019s diseases. Neurosci Lett 58:343\u2013346","journal-title":"Neurosci Lett"},{"key":"548_CR20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofic E, Rausch WD et al (1989) Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J Neurochem 52:515\u2013520","journal-title":"J Neurochem"},{"key":"548_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0166-2236(93)90070-3","volume":"16","author":"CW Olanow","year":"1993","unstructured":"Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16:439\u2013444","journal-title":"Trends Neurosci"},{"key":"548_CR22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0891-5849(91)90009-R","volume":"10","author":"JD Adams","year":"1991","unstructured":"Adams JD, Odunze IN (1991) Oxygen free radicals and Parkinson\u2019s diseases. Free Radical Biol Med 10:161\u2013169","journal-title":"Free Radical Biol Med"},{"key":"548_CR23","first-page":"242","volume":"60","author":"N Ogawa","year":"1993","unstructured":"Ogawa N, Edamatsu R, Mizukawa K et al (1993) Degeneration of dopaminergic neurons and free radicals: possible participation of levodopa. Adv Neurol 60:242\u2013250","journal-title":"Adv Neurol"},{"key":"548_CR24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0304-3940(94)90603-3","volume":"171","author":"N Ogawa","year":"1994","unstructured":"Ogawa N, Asanuma M, Kondo Y et al (1994) Differential effects of chronic L-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine. Neurosci Lett 171:55\u201358","journal-title":"Neurosci Lett"},{"key":"548_CR25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(89)91530-8","volume":"476","author":"JL Cadet","year":"1989","unstructured":"Cadet JL, Katz M, Jackson-Lewis V et al (1989) Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res 476:10\u201315","journal-title":"Brain Res"},{"key":"548_CR26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/mutage\/geq043","volume":"25","author":"BN Rao","year":"2010","unstructured":"Rao BN, Rao BS (2010) Antagonistic effects of zingerone, a phenolic alkanone against radiation-induced cytotoxicity, genotoxicity, apoptosis and oxidative stress in Chinese hamster lung fibroblast cells growing in vitro. Mutagenesis 25:577\u2013587","journal-title":"Mutagenesis"},{"key":"548_CR27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2174\/138161210790883615","volume":"16","author":"V Calabrese","year":"2010","unstructured":"Calabrese V, Comelius C, Trovato A, Cavallaro M et al (2010) The hermetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des 16:877\u2013883","journal-title":"Curr Pharm Des"},{"key":"548_CR28","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1055\/s-2008-1074578","volume":"74","author":"BB Aggarwal","year":"2008","unstructured":"Aggarwal BB, Kunnumakkara AB, Harikumar KB et al (2008) Potential of spice-derived phytochemicals for cancer prevention. Planta Med 74:1560\u20131569","journal-title":"Planta Med"},{"key":"548_CR29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/187152809787582561","volume":"8","author":"S Hasana-Ranjbar","year":"2009","unstructured":"Hasana-Ranjbar S, Larijani B, Abdollahi M (2009) A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm Allergy Drug Targets 8:2\u201310","journal-title":"Inflamm Allergy Drug Targets"},{"key":"548_CR30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000212750","volume":"61","author":"JK Kundu","year":"2009","unstructured":"Kundu JK, Na HK, Surh YJ (2009) Ginger-derived phenolic substances with cancer preventive and therapeutic potential. Forum Nutr 61:182\u2013192","journal-title":"Forum Nutr"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-011-0548-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0548-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T07:24:54Z","timestamp":1638084294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-011-0548-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,19]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1007\/s11064-011-0548-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,19]]}}}